Board Name | Posts By MythicSphinx35 | Post Created |
---|---|---|
DRRX Durect Corp. | Jim Brown CEO stated the following: | 08/14/2024 3:31:46 AM |
DRRX Durect Corp. | Highlights/Summary of DRRX Conferen ![]() | 08/14/2024 1:58:33 AM |
DRRX Durect Corp. | Up 26.67% today! Looks like FDA Bre | 05/31/2024 7:10:51 PM |
DRRX Durect Corp. | In my opinion the Breakthrough Ther | 05/21/2024 11:09:10 PM |
DRRX Durect Corp. | DRRX receives Breakthrough Therapy ![]() | 05/21/2024 2:19:38 PM |
DRRX Durect Corp. | FDA Update & Key Points: “We are | 05/13/2024 6:45:51 PM |
DRRX Durect Corp. | DUR-928, also known as larsucostero ![]() | 05/05/2024 11:49:24 PM |
DRRX Durect Corp. | Mortality Benefit: The substantial ![]() | 05/04/2024 6:00:30 PM |
DRRX Durect Corp. | By focusing specifically on the sig ![]() | 05/04/2024 2:47:01 AM |
DRRX Durect Corp. | Deeper Dive into DUR-928 Hypothetic ![]() | 05/03/2024 12:26:17 PM |
DRRX Durect Corp. | Lets assume that liver transplant r ![]() | 05/02/2024 6:24:02 PM |
Recent Articles
- Exploring Affordable Education with The Global Citizen Hub
- IEHP Responds to DOJ Filing with Strong Defense Commitments
- Faruqi & Faruqi Investigates Legal Options for RxSight Investors
- Investigating Alto Neuroscience: Investor Claims and Updates
- AquaBounty Technologies' Astounding After-Hours Stock Surge
- Fangzhou Shines as Leading Innovator in Healthcare Technology
- Investigation Launched by Faruqi & Faruqi on Fiserv Losses
- Insights on Cracker Barrel, D-Wave, IonQ, Krispy Kreme & Broadcom
- Louisville Vegan Jerky Joins Forces with Louisville Brands
- Miami Seaquarium Remembers Bimini, Beloved 26-Year-Old Dolphin
- Harnessing Technology to Transform the Future of Elderly Care
- Savara Inc. Investors Encouraged to Explore Legal Options
- Wayfyndr Enhances Fan Experience with New Partnerships
- Investigation Launched into Quantum Corporation for Investors
- Understanding the Legal Landscape for V.F. Corporation Shareholders
- Meta Launches Cutting-Edge Smart Glasses for Tech Enthusiasts
- Investors Alert on Fluor Corporation Class Action Updates
- Neuronata-R® Shows Promise for ALS Patients at Global Congress
- Discover My Main AI INC's Upcoming Enhancements for Users
- Innovative Partnership: Xpore and Patagonia's Sustainable Journey
- Wayfyndr Unveils Enhanced Fan Engagement with New Partners
- FEMSA's New Leadership: A Vision for Strategic Growth
- Investors Rally for Replimune: An Opportunity for Recovery
- Cryptocurrency Market Insights: Rate Cuts and Price Predictions
- Exploring the EBSCO Scholarly Graph: A New Era for Research
- Innovative Collaboration for Autonomous Construction Tech
- FEMSA's New CEO: A Vision for Future Growth and Sustainability
- Flywire Investors: Legal Insights on Upcoming Claims and Deadlines
- Investigation Launched into PubMatic by Faruqi & Faruqi, LLP
- Cathie Wood's Investment Moves: Bullish Trends and Strategic Exits
- Garmin Collaborates with Meta to Enhance AI Glasses Performance
- EssilorLuxottica and Meta Unveil Next-Gen AI Glasses in 2025
- Chenghe Acquisition III Co. Successfully Completes IPO Raising $126.5 Million
- Investor Alert: Tronox Holdings Faces Legal Scrutiny
- New Investigations Open for SelectQuote Investors Amid Concerns
- CAIXA ECONÔMICA FEDERAL Sees Tremendous Growth in 2025
- Celebrating Upcoming Leaders in Emergency Nursing for 2025
- Revolutionizing M&A: Navatar Enhances Deal Management with AI
- Investigation of Nutex Health Inc. by Faruqi & Faruqi, LLP
- Investigation Launched for Lockheed Martin Investor Claims
- Fangzhou Inc. Celebrates Gilead Excellence Award Success
- Explore Top Kitchen Flooring Choices with Roman Keim
- Investigation Launched Into Semler Scientific Investor Claims
- Investors of Charter Communications Face Legal Investigation
- State Department's Censorship Practices Under Scrutiny
- Investigation into Unicycive Therapeutics Sparks Investor Interest
- Impressive Growth Report: CAIXA Economic Performance in 2025
- Chongqing Hosts Revolutionary Robotics Competition Showcasing AI Innovations
- Minute Media's Strategic Move: Acquiring VideoVerse's AI Technology
- Clinical Study Results of Telitacicept at Major Medical Meeting